This company seems to have been delisted
Reason: Merged with Ayala Pharmaceuticals
Last recorded trade on: March 21, 2025
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Reason: Merged with Ayala Pharmaceuticals
Last recorded trade on: March 21, 2025
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Advaxis
ADXS
0,02639 €
Share price
0.00%
Change (1 day)
-95.21%
Change (1 year)
Categories
Advaxis (ADXS) - Net assets
Net assets on the balance sheet as of December 2023 : -€21.48 Million
According to Advaxis's latest financial reports the company has -€21.48 Million in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Advaxis - Net assets on balance sheet (from 2019 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-€22.09 Million | 2055.85% |
| 2022-12-31 | $-€1.03 Million | -103.4% |
| 2021-12-31 | $€30.16 M | -3.38% |
| 2020-12-31 | $€31.21 M | -189.85% |
| 2019-12-31 | $-€34.75 Million | 81.83% |
| 2018-12-31 | $-€19.11 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | €60.25 M | -380.56% | 🇺🇸 USA |
 | €10.89 M | -150.72% | 🇺🇸 USA |
 | €0.36 B | -1,810.57% | 🇺🇸 USA |